XTNT (Xtant Medical Holdings) ערך חשבונאי למניה

The book value per share reflects capital dynamics, where the current status is 0.29. Xtant Medical Holdings generates revenue through the supply of spinal surgery instruments and implants. Production relies on robotic lines and AI-driven sterility control for biomaterials. A niche focus on bone grafting is complemented by an extensive distribution channel across US clinics, which minimizes operational risks.

Stable sales of orthopedic solutions from Xtant Medical Holdings support working capital, allowing the real value of the business to be tracked via the BVPS valuation. This indicator is calculated as the difference between all assets and liabilities divided by the number of shares, reflecting the net value of an investor's stake and confirming the resilience of the company's equity to market fluctuations.